Assembly Biosciences, Inc. Deferred Tax Assets, Unrealized Losses on Trading Securities
Assembly Biosciences, Inc. (ASMB) had Deferred Tax Assets, Unrealized Losses on Trading Securities of $46.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities · last filed 2018-03-08
- 2017-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $46.00K.
- 2016-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $178.00K.
- 2015-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $368.00K.
- 2014-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $0.00.
| Period end | Deferred Tax Assets, Unrealized Losses on Trading Securities |
|---|---|
| 2017-12-31 | $46.00K 10-K · filed 2018-03-08 |
| 2016-12-31 | $178.00K 10-K · filed 2018-03-08 |
| 2015-12-31 | $368.00K 10-K · filed 2017-03-02 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |